Healthspan Industry Players
Who participates in the healthcare community — and what positions does each player fill?
Players are the community of participants in the healthcare ecosystem — the WHO. Positions are the roles those players fill — the WHAT. The hat changes; the player remains. (Doctrinal anchor: Ecosystem — every industry has a community of participants.)
The Ecosystem
The healthcare community has four sides:
- Buyers — patients, employers, and payers who consume care and bear its cost
- Providers — clinicians, health systems, and digital-health platforms that produce the care
- Infrastructure — EHR vendors, device makers, DePIN sensor networks, data platforms, and pharma supply chains the industry runs on
- Boundary — regulators (FDA, CMS, HIPAA), standards bodies (HL7/FHIR), payer credentialing, and accreditation authorities that set the rules
Every player wears multiple hats. A wearable-device company is simultaneously infrastructure (providing continuous sensor data) and supplier (selling hardware to providers and consumers) and, through DePIN protocols, a node in a decentralised data marketplace. The position changes per transaction; the player remains.
The five-counterparty model from Ecosystem maps to this industry as follows:
| Counterparty (canonical) | Healthcare expression |
|---|---|
| Customers | Patients, employers buying group coverage, government payers (Medicare, Medicaid), insurers |
| Suppliers | Pharma and device manufacturers, clinical-trial CROs, medical-supply distributors, energy and facility operators |
| Employees | Physicians, nurses, allied health professionals, care coordinators, administrators, AI-ops staff |
| Owners | Health system boards, private-equity-backed specialty groups, digital-health venture investors, DeSci DAOs |
| Regulators | FDA, CMS, HIPAA Office, state medical boards, HL7/FHIR standards bodies, IRBs |
Buyer side — players
The buyers of healthcare output. The value-generators the industry exists to serve. Player = the WHO. Position filled = what they buy.
| Player (WHO) | Position filled — what they buy | Asymmetry they need closed | Archetype |
|---|---|---|---|
| Individual patient | Relief from pain, restoration of function, longevity | Information asymmetry vs clinician; insurance labyrinth | Dreamer (wants outcome) / Realist (navigating system) |
| Employer (self-insured) | Group health coverage + productivity outcomes | Cost per member per year; outcome attribution | Realist |
| Government payer (CMS, NHS) | Population health outcomes at scale | Value-based contracting; fraud detection; adherence | Realist |
| Private insurer | Risk pools + premium income margin | Adverse selection; prior-auth burden vs clinical loss | Realist |
| Employer benefits broker | Plan design + administration + compliance | Matching plan design to workforce health profile | Engineer |
| Direct-primary-care subscriber | Ongoing access + preventive protocols | Predictable cost; accessibility outside office hours | Coach |
Provider side — players
The professionals and organisations that produce the care. Player = the WHO. Position filled = what they provide.
| Player (WHO) | Position filled — what they provide | Where they compete | Archetype |
|---|---|---|---|
| Hospital system (Epic-anchored) | Acute care + specialist referral + emergency | Geographic monopoly; payer contract leverage | Realist |
| Independent specialty group (PE-backed) | High-margin specialty (derm, ortho, ophthalmology) | Reimbursement arbitrage + AI-augmented throughput | Engineer |
| Primary care / value-based group (e.g. Pearl Health) | Outcome-attributed chronic disease management | Data ownership + outcome measurement layer | Realist / Coach |
| Behavioral health platform (virtual-first) | Therapy + psychiatry at scale via video | Shortest regulatory path; highest unmet demand | Dreamer |
| AI-first primary care (e.g. Forward Health Pods) | Hardware + AI removes the human bottleneck for routine care | Radical throughput; membership model | Engineer |
| Digital therapeutics / app-based care | Evidence-based interventions delivered at software marginal cost | FDA De Novo clearance as moat; subscription model | Engineer |
| Home health + remote monitoring | Continuous care outside the facility | Wearable data + CMS Remote Patient Monitoring billing codes | Engineer |
| DeSci DAO (e.g. AthenaDAO) | Community-funded research for underserved disease areas | Token-aligned incentive to fund research pharma ignores | Philosopher |
Infrastructure side — players
The technology, data, and supply providers the industry operates on. Player = the WHO. Position filled = what they provide.
| Player (WHO) | Position filled — what they provide | Disruption vector | Archetype |
|---|---|---|---|
| EHR incumbent (Epic, Oracle Health/Cerner) | System of record + billing + care coordination | Lock-in via switching cost; FHIR mandate creates edge cracks | Realist |
| Medical device OEM (Medtronic, Abbott, Philips) | Diagnostic and therapeutic hardware | AI co-pilots embedded inside existing device ecosystems | Engineer |
| Wearable / continuous monitor (Apple Watch, Dexcom, Oura) | Consumer-grade continuous biometric streams | DePIN-adjacent; patient-owned data layer forming | Engineer / Dreamer |
| Pharma supply chain (McKesson, AmerisourceBergen) | Drug distribution + cold-chain logistics | Serialisation mandates (DSCSA) as on-chain attestation opportunity | Realist |
| Clinical-AI platform (AI diagnostics: Viz.ai, Paige.ai) | Domain-specific model deployment for imaging and pathology | Speed to FDA clearance; workflow integration is the moat | Engineer |
| FHIR API and interoperability layer (Health Gorilla, 1upHealth) | Structured data exchange between EHRs, payers, apps | CMS interoperability rule forces EHR openness; they capture the gap | Engineer |
| DeSci protocol (LabDAO, VitaDAO, AthenDAO) | Decentralised funding + data-sharing infrastructure for research | Token-aligned incentives unlock research pharma won't fund | Philosopher / Dreamer |
| ZK-proof / patient-data-sovereignty layer | Cryptographic patient consent + data-sharing without exposing PII | Pre-regulatory; builds the foundation for the post-HIPAA model | Engineer |
Boundary side — players
Sets the rules the other three sides operate inside. Player = the WHO. Position filled = function held in the system.
| Player (WHO) | Position filled — function held | Repeat-player advantage |
|---|---|---|
| FDA (US Food and Drug Administration) | Drug and device approval; digital-health software classification | Deep domain expertise; sets the evidence bar |
| CMS (Centers for Medicare and Medicaid Services) | Reimbursement coding; value-based contract design | Controls what gets paid — the most powerful lever in US healthcare |
| HIPAA Office for Civil Rights | Privacy rule enforcement; breach notification | Audit and penalty authority creates institutional compliance culture |
| State medical licensing boards | Clinician licensure + scope-of-practice rules | Jurisdiction-by-jurisdiction variation is the telemedicine moat |
| HL7 / FHIR standards body | Data interoperability specification | Standards adoption = market structure; FHIR R4 is now the baseline |
| IRB (Institutional Review Boards) | Human-subjects research approval | Gatekeepers for clinical-trial launch; accredited IRBs move faster |
| Private payer credentialing networks | Provider participation in-network | Network inclusion = revenue; credentialing is the slow administrative tax |
The Five Archetypes Across the Community
The fractal pattern names five archetypes that appear at every layer of every system. Healthcare is no exception.
- Dreamer — The patient holding a vision of full health. The DeSci researcher building the protocol pharma ignores. The digital-health founder who sees the care model that doesn't require a building.
- Realist — The GC who reads every payer contract. The hospital CFO who prices risk into every capital allocation. The government actuary running population cohort models. The one who says "will this actually survive a CMS audit?"
- Engineer — The EHR implementation lead. The AI-diagnostics engineer clearing FDA De Novo. The CRO operations director running adaptive trial designs. The one who makes the system run at compliance-grade.
- Coach — The primary care physician who has known the patient for fifteen years. The care coordinator who holds the whole picture. The clinical educator developing the next cohort of nurses and allied health professionals.
- Philosopher — The bioethicist asking whether AI diagnostics introduce algorithmic bias. The longevity researcher running the trial no payer will fund. The DeSci community asking "what would it cost to run this study if we didn't need pharma?"
A healthy healthcare community has all five archetypes present. When the Realist and Engineer dominate and the Philosopher disappears, research concentrates on what reimburses — and the disease areas with no paying constituency go dark.
Positions Matrix — Human vs AI Split
Players hold positions. Each position has a human-vs-AI split that is shifting. The hat changes; the player remains — but AI does an increasing share of the work inside the hat.
| Position | Human today | AI today | Direction (3–5 years) |
|---|---|---|---|
| Specialist physician (diagnosis-heavy: radiologist, pathologist) | 100% human interpretation | AI matches specialist accuracy on standard cases | Human-led for complex / edge cases; AI handles volume first-pass |
| Primary care physician | 100% human | AI pre-populates notes, flags gaps in care protocols | Fewer PCPs needed per panel; AI extends reach |
| Nurse / allied health | 100% human at bedside | AI triages and monitors between visits | Nurse role shifts toward judgment calls AI cannot make |
| Prior authorisation reviewer | Human judgment + rule lookup | AI automates 80%+ of standard-criteria cases | Significant headcount pressure; residual is appeals and edge |
| Clinical coder / biller | Human interpretation of complex cases | AI codes standard encounters at high accuracy | Volume work AI-only within 3 years |
| Drug-discovery chemist | Human hypothesis + bench work | AI protein folding + molecular simulation compresses timelines | Human directs high-level strategy; AI runs the combinatorial search |
| Care coordinator | Human relationship + continuity | AI flags gaps, surfaces risk scores, schedules follow-up | Smaller team handles larger panels; relationship layer stays human |
| Regulatory affairs specialist | 100% human | AI drafts submissions; regulatory-language models emerging | Human review required; AI cuts preparation time by 60%+ |
| Clinical trial monitor | Human site visits + data review | AI flags protocol deviations in real time | Remote monitoring with AI oversight becomes standard |
Archetype Asymmetries — Industry Level
| Archetype | What they bring | Where they win in healthcare |
|---|---|---|
| Dreamer | Vision of care that compounds health rather than managing disease | Rallying DeSci capital; designing the continuous monitoring model before reimbursement exists |
| Engineer | Domain craft in regulatory navigation, EHR integration, clinical validation | Building the AI diagnostic pipeline; running the adaptive trial; making FHIR interoperability real |
| Realist | Actuarial discipline; payer-contract depth; compliance posture | Designing the value-based contract; defending the evidence standard; saying NO to the outcome claim without the data |
| Coach | Longitudinal patient relationship; clinical educator depth; continuity of care | Primary care at scale; developing the next generation of clinicians; holding care-coordination across the fragmented system |
| Philosopher | Bioethics; DeSci conviction; willingness to fund research with no reimbursement path | Asking which disease areas are invisible to the market and why; designing the patient-sovereign data model |
The Sales Cycle Is the Moat
Healthcare has the highest AI leverage of any industry but the longest sales cycle. The positioning window is the gap between what AI can do and what the industry has adopted.
Three operational realities for any player entering this community:
- Sub-vertical first. Behavioral health and home health have the shortest regulatory path and the deepest unmet demand. Hospital systems are the last mile. Enter where friction is lowest; compound toward the high-friction segments.
- FHIR is the wedge. CMS interoperability mandates force EHR openness. Any infrastructure player that can consume and produce FHIR R4 is positioned to route around the EHR lock-in moat.
- Outcome data is the moat. Whoever owns longitudinal patient outcome data owns value-based contracting. The EHR vendors know this. The DeSci protocols are building the alternative: patient-sovereign outcome data the system can't lock away.
Context
- depends-on Community → Ecosystem — Five-counterparty model; the hat changes, the player remains
- applies-to Community → Archetypes — The five archetypes mapped across this community
- pairs-with Healthcare Index — Disruption scoring, friction map, sub-vertical entry ranking
- pairs-with Medical Science — The research frontier these players produce and consume
- pairs-with DePIN — Sensor networks for continuous patient monitoring — the infrastructure players building the data layer
- instance-of Standard Templates → Players — Written from the players template
Questions
- Which counterparty's perspective is most invisible in this industry — and what routing signal gets missed as a result?
- If patient data sovereignty becomes real (DeSci + ZK proofs), does the EHR lock-in moat collapse overnight or erode over a decade?
- When AI diagnostics match specialist accuracy on standard cases, what is the residual asymmetry that keeps the Philosopher and Coach irreplaceable?
- Which archetype is underrepresented on the boundary side — and what does that explain about which disease areas go unfunded?